Previous Page  176 / 194 Next Page
Information
Show Menu
Previous Page 176 / 194 Next Page
Page Background

174

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

126

Haane DY, Dirkx TH, Koehler PJ. The history of oxygen inhalation as a treatment for cluster

headache. Cephalalgia. 2012 Sep;32(12):932-9.

127

Hagen K, Albretsen C, Vilming ST, Salvesen R, Grønning M, Helde G, Gravdahl G, Zwart JA,

Stovner LJ. A 4-year follow-up of patients with medication-overuse headache previously

included in a randomized multicentre study. J Headache Pain. 2011 Jun;12(3):315-22.

128

Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse

headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain. 2012

Jan;153(1):56-61.

129

Hagen K, Stovner LJ. A randomized controlled trial on medication-overuse headache:

outcome after 1 and 4 years. Acta Neurol Scand Suppl. 2011;(191):38-43.

130

Halpert AG, Olmstead MC, Beninger RJ. Mechanisms and abuse liability of the anti-hista-

mine dimenhydrinate. Neurosci Biobehav Rev. 2002 Jan;26(1):61-7. Review.

131

Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the

acute treatment of migraine in children: a double-blind, randomized, placebo-controlled,

crossover study. Neurology. 1997 Jan;48(1):103-7.

132

Hamel E. The biology of serotonin receptors: focus on migraine pathophysiology and

treatment. Can J Neurol Sci. 1999 Nov;26 Suppl 3:S2-6. Review.

133

Hardebo JE, Dahlöf C. Sumatriptan nasal spray (20 mg/dose) in the acute treatment of

cluster headache. Cephalalgia. 1998 Sep;18(7):487-9.

134

Hardebo JE. Subcutaneous sumatriptan in cluster headache: a time study of the effect on

pain and autonomic symptoms. Headache. 1993 Jan;33(1):18-21.

135

Headache Classification Committee of the International Headache Society IHS). The

International Classification of Headache Disorders, 3rd edition betaversion. Cephalalgia.

2013 Jul;33(9):629-808.

136

Headache Classification Subcommittee of the International Headache Society. The Inter-

national Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 Suppl

1:9-160.

137

Headache Classification Subcommittee of the International Headache Society. The Inter-

national Classification of Headache Disorders: 2nd edition. Cephalalgia.2004;24 Suppl

1:9-160.

138

Hedlund C, Rapoport AM, Dodick DW, Goadsby PJ. Zolmitriptan nasal spray in the

acute treatment of cluster headache: a meta-analysis of two studies. Headache. 2009

Oct;49(9):1315-23.

139

Heinze A, Heinze-Kuhn K, Göbel H. Classification of headache disorders. Schmerz. 2007

Jun;21(3):263-73

140

Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing

migraineurs. Lancet. 1991 Jun 15;337(8755):1442-3.

141

Holle D, Obermann M. The role of neuroimaging in the diagnosis of headache disorders.

Ther Adv Neurol Disord. 2013 Nov;6(6):369-74.